Linked Data API

Show Search Form

Search Results

846086
registered interest false more like this
date less than 2018-02-21more like thismore than 2018-02-21
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Orphan Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that NHS England and NICE revise their appraisal criteria for the NICE Highly Specialised Technologies as a result of the Scottish Medicines Consortium’s review of the definition of orphan and ultra-orphan designation route to include condition prevalence criteria; and if he will ensure that they publish those prevalence criteria. more like this
tabling member constituency Linlithgow and East Falkirk more like this
tabling member printed
Martyn Day remove filter
uin 128793 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-03-01more like thismore than 2018-03-01
answer text <p>The Government and the National Institute for Health and Care Excellence (NICE) have no plans to review the criteria for the selection of topics for referral to NICE’s Highly Specialised Technologies (HST) programme. The topic selection criteria for HST are published at:</p><p> </p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/topic-selection" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/topic-selection</a></p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
remove filter
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4488
label Biography information for Martyn Day more like this